| Entry |
|
|---|
| Name |
Entospletinib (USAN/INN) |
|---|
| Formula |
C23H21N7O
|
|---|
| Exact mass |
411.1808
|
|---|
| Mol weight |
411.46
|
|---|
| Structure |
|
|---|
| Class |
Antineoplastic
DG01918 Tyrosine kinase inhibitor
|
|---|
| Efficacy |
Antineoplastic, Tyrosine kinase inhibitor |
|---|
| Comment |
Treatment of lymphoma and leukemia
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
D11209 Entospletinib
Target-based classification of drugs [BR:br08310]
Protein kinases
Non-receptor tyrosine kinases
SYK family
SYK
D11209 Entospletinib (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 31
1 C8y C 13.6467 -19.6650
2 C8y C 13.6467 -21.0646
3 C8x C 14.8588 -21.7645
4 C8x C 16.0710 -21.0646
5 C8y C 16.0710 -19.6650
6 C8x C 14.8588 -18.9652
7 N4x N 12.3156 -19.2325
8 N5x N 11.4929 -20.3648
9 C8x C 12.3156 -21.4971
10 C8y C 17.3017 -18.9542
11 C8x C 18.5066 -19.6497
12 N4y N 19.7186 -18.9498
13 C8y C 19.7186 -17.5502
14 C8y C 18.5137 -16.8547
15 N5x N 17.3016 -17.5546
16 C8x C 21.0498 -19.3822
17 C8x C 21.8724 -18.2499
18 N5x N 21.0496 -17.1176
19 N1b N 18.5139 -15.4665
20 C8y C 19.7497 -14.7528
21 C8x C 20.9566 -15.4497
22 C8x C 22.1686 -14.7497
23 C8y C 22.1686 -13.3501
24 C8x C 20.9616 -12.6534
25 C8x C 19.7496 -13.3532
26 N1y N 23.3852 -12.6476
27 C1x C 24.5973 -13.3472
28 C1x C 25.8092 -12.6473
29 O2x O 25.8091 -11.2477
30 C1x C 24.5971 -10.5481
31 C1x C 23.3851 -11.2480
BOND 36
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 1 7 1
8 7 8 1
9 8 9 2
10 2 9 1
11 5 10 1
12 10 11 2
13 11 12 1
14 12 13 1
15 13 14 1
16 14 15 2
17 10 15 1
18 12 16 1
19 16 17 2
20 17 18 1
21 13 18 2
22 14 19 1
23 19 20 1
24 20 21 2
25 21 22 1
26 22 23 2
27 23 24 1
28 24 25 2
29 20 25 1
30 23 26 1
31 26 27 1
32 27 28 1
33 28 29 1
34 29 30 1
35 30 31 1
36 26 31 1
|
|---|
